ACAD
40.375
+0.155
+0.385%
AEMD
8.85
0.00
0.00%
APRI
1.54
+0.04
+2.67%
ARNA
4.203
+0.003
+0.0619%
ATEC
1.35
+0.00
+0.0074%
CNAT
5.26
-0.06
-1.13%
CRXM
0.5
0.00
0.00%
CYTX
0.674
-0.007
-1.013%
DXCM
68.53
+0.28
+0.41%
GNMK
9.06
+0.03
+0.33%
HALO
17.34
+0.09
+0.52%
ILMN
203.46
+0.34
+0.17%
INNV
0.15
0.00
0.00%
INO
8.2
-0.06
-0.73%
ISCO
0.05
0.00
-0.2000%
ISIS
67.52
+0.35
+0.52%
LGND
89.2
-0.03
-0.03%
LPTN
0.31
+0.01
+4.38%
MBVX
2.42
+0.04
+1.68%
MEIP
1.919
+0.009
+0.4817%
MNOV
4
0.00
0.00%
MRTX
26.03
+0.19
+0.74%
MSTX
0.5
0.00
-0.99%
NBIX
42.99
+1.01
+2.41%
NUVA
48.25
+0.02
+0.04%
ONCS
0.233
0.00
0.00%
ONVO
4.72
+0.04
+0.85%
OREX
4.97
-0.03
-0.60%
OTIC
25.46
-5.59
-18.00%
QDEL
22.54
-0.19
-0.84%
RCPT
160.432
+0.322
+0.2014%
RGLS
12.799
+0.049
+0.384%
RMD
57.22
-0.1
-0.17%
SCIE
0.015
0.00
0.00%
SPHS
0.842
-0.018
-2.0373%
SRNE
13.12
-0.09
-0.68%
TROV
10.36
+0.07
+0.68%
VICL
0.9
+0.01
+1.1124%
VOLC
17.99
0.00
0.00%
ZGNX
1.405
+0.005
+0.357%
ACAD
40.375
+0.155
+0.385%
AEMD
8.85
0.00
0.00%
APRI
1.54
+0.04
+2.67%
ARNA
4.203
+0.003
+0.0619%
ATEC
1.35
+0.00
+0.0074%
CNAT
5.26
-0.06
-1.13%
CRXM
0.5
0.00
0.00%
CYTX
0.674
-0.007
-1.013%
DXCM
68.53
+0.28
+0.41%
GNMK
9.06
+0.03
+0.33%
HALO
17.34
+0.09
+0.52%
ILMN
203.46
+0.34
+0.17%
INNV
0.15
0.00
0.00%
INO
8.2
-0.06
-0.73%
ISCO
0.05
0.00
-0.2000%
ISIS
67.52
+0.35
+0.52%
LGND
89.2
-0.03
-0.03%
LPTN
0.31
+0.01
+4.38%
MBVX
2.42
+0.04
+1.68%
MEIP
1.919
+0.009
+0.4817%
MNOV
4
0.00
0.00%
MRTX
26.03
+0.19
+0.74%
MSTX
0.5
0.00
-0.99%
NBIX
42.99
+1.01
+2.41%
NUVA
48.25
+0.02
+0.04%
ONCS
0.233
0.00
0.00%
ONVO
4.72
+0.04
+0.85%
OREX
4.97
-0.03
-0.60%
OTIC
25.46
-5.59
-18.00%
QDEL
22.54
-0.19
-0.84%
RCPT
160.432
+0.322
+0.2014%
RGLS
12.799
+0.049
+0.384%
RMD
57.22
-0.1
-0.17%
SCIE
0.015
0.00
0.00%
SPHS
0.842
-0.018
-2.0373%
SRNE
13.12
-0.09
-0.68%
TROV
10.36
+0.07
+0.68%
VICL
0.9
+0.01
+1.1124%
VOLC
17.99
0.00
0.00%
ZGNX
1.405
+0.005
+0.357%
Home » Archive by Category

Diagnostics

San Diego’s Biotechnology Companies: Who’s Taking Off?

March 8, 2012 – 9:13 am

Here at SDBN we’ve been updating our directory of 400+ San Diego biotech companies.  We were surprised to find close to 40 companies removed from the local scene – due to acquisition or shut down.  …

The Future of Personal Genetic Testing and Diagnostics with Pathway Genomics

August 26, 2011 – 9:57 am

The Pathway Genomics business model is based on bridging a gap in personalized medicine.  As Ed MacBean, their VP of Product Development, explained at SDBN’s August 16th event, in a nutshell they connect clients through …

SDBN August 16th 2011 Event Featuring Pathway Genomics

July 29, 2011 – 9:41 am

We polled you late last year about events you’d like us to have in 2011, and diagnostics was one of the top items on the list. In San Diego, we have a great atmosphere for …